Literature DB >> 15207645

7-12 Dimethylbenz[a]anthracene-induced bone marrow hypocellularity is dependent on signaling through both the TNFR and PKR.

Todd J Page1, Peter S MacWilliams, M Suresh, Colin R Jefcoate, Charles J Czuprynski.   

Abstract

In addition to being carcinogenic, polycyclic aromatic hydrocarbons (PAHs) are known to cause deleterious effects on the immune system, including a marked reduction in bone marrow granulocytes and B lymphocytes. The molecular mechanisms underlying bone marrow hypocellularity are incompletely understood. Hematopoiesis is governed by the production of cytokines and the resultant signaling pathways that they initiate. Our hypothesis was that PAHs may disrupt cytokine production in the bone marrow resulting in the perturbation in bone marrow cellularity observed after PAH administration. TNF-alpha and IFN-gamma are two cytokines that are involved in the regulation of hematopoiesis. Based on observations made in previous research, we sought to determine if the effects of 7-12 dimethylbenz[a]anthracene (DMBA) on the murine bone marrow were mediated through the actions of these molecules. Transgenic mice that were null for either IFN-gamma or TNF-alpha receptors were injected with DMBA and the resulting bone marrow cellularity compared with wild-type mice. We observed that tumor necrosis factor alpha receptor (TNFR) null mice were protected against DMBA-induced bone marrow hypocellularity, while IFN-gamma null mice were not. In addition, we found that dsRNA-dependent protein kinase (PKR) null mice were also protected from DMBA-induced hypocellularity. PKR is an intracellular signaling molecule that has been demonstrated to be activated by TNFR-mediated signaling. Furthermore, we observed upregulation of PKR in the bone marrow after DMBA administration that was dependent on signaling through TNFR. These results point to a role for TNFR-dependent signaling, operating at least in part via PKR activation, as a mechanism for DMBA-induced bone marrow toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207645     DOI: 10.1016/j.taap.2004.02.014

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

Review 1.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

2.  Bone marrow lymphoid and myeloid progenitor cells are suppressed in 7,12-dimethylbenz(a)anthracene (DMBA) treated mice.

Authors:  A U N'jai; M Larsen; L Shi; C R Jefcoate; C J Czuprynski
Journal:  Toxicology       Date:  2010-02-18       Impact factor: 4.221

3.  Acute disruption of bone marrow hematopoiesis by benzo(a)pyrene is selectively reversed by aryl hydrocarbon receptor-mediated processes.

Authors:  Alhaji U N'jai; Michele C Larsen; Justin R Bushkofsky; Charles J Czuprynski; Colin R Jefcoate
Journal:  Mol Pharmacol       Date:  2011-01-20       Impact factor: 4.436

4.  PKR regulates proliferation, differentiation, and survival of murine hematopoietic stem/progenitor cells.

Authors:  Xiangfei Liu; Richard L Bennett; Xiaodong Cheng; Michael Byrne; Mary K Reinhard; W Stratford May
Journal:  Blood       Date:  2013-02-12       Impact factor: 22.113

5.  Cyp1b1-mediated suppression of lymphoid progenitors in bone marrow by polycyclic aromatic hydrocarbons coordinately impacts spleen and thymus: a selective role for the Ah Receptor.

Authors:  Michele Campaigne Larsen; Alhaji U N'Jai; David L Alexander; Catherine M Rondelli; E C Forsberg; Charles J Czuprynski; Colin R Jefcoate
Journal:  Pharmacol Res Perspect       Date:  2016-07-29

Review 6.  Nano-selenium and its nanomedicine applications: a critical review.

Authors:  Bozena Hosnedlova; Marta Kepinska; Sylvie Skalickova; Carlos Fernandez; Branislav Ruttkay-Nedecky; Qiuming Peng; Mojmir Baron; Magdalena Melcova; Radka Opatrilova; Jarmila Zidkova; Geir Bjørklund; Jiri Sochor; Rene Kizek
Journal:  Int J Nanomedicine       Date:  2018-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.